File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Chemical pathology case conference - Serum tumour markers

TitleChemical pathology case conference - Serum tumour markers
Authors
Poon, WTYuen, YPMak, CMChan, AOKChan, MHMChiu, RWKLam, CWMak, TWLShek, CCTai, MHLTam, SChan, AYW
Issue Date2010
PublisherHong Kong College of Family Physicians. The Journal's web site is located at http://www.hkcfp.org.hk/
Citation
Hong Kong Practitioner, 2010, v. 32 n. 1, p. 27-33 How to Cite?
AbstractTumour markers are mainly measured in clinical laboratories. A distinction should be made between tumour markers and tumour-specific markers. Utmost caution should be exercised in the interpretation of tumour-marker results because of analytical interference and overlap with benign conditions. The use of a tumour marker for early detection of malignancy is challenging because of its low positive predictive value. However, with an understanding of the performance characteristics of tumour markers and correct interpretation of the results, tumour markers are useful in clinical management of diseases.
Persistent Identifierhttp://hdl.handle.net/10722/148619
ISSN
1027-3948
2020 SCImago Journal Rankings: 0.101
References
References in Scopus

 

DC FieldValueLanguage
dc.contributor.authorPoon, WTen_US
dc.contributor.authorYuen, YPen_US
dc.contributor.authorMak, CMen_US
dc.contributor.authorChan, AOKen_US
dc.contributor.authorChan, MHMen_US
dc.contributor.authorChiu, RWKen_US
dc.contributor.authorLam, CWen_US
dc.contributor.authorMak, TWLen_US
dc.contributor.authorShek, CCen_US
dc.contributor.authorTai, MHLen_US
dc.contributor.authorTam, Sen_US
dc.contributor.authorChan, AYWen_US
dc.date.accessioned2012-05-29T06:14:08Z-
dc.date.available2012-05-29T06:14:08Z-
dc.date.issued2010en_US
dc.identifier.citationHong Kong Practitioner, 2010, v. 32 n. 1, p. 27-33en_US
dc.identifier.issn1027-3948en_US
dc.identifier.urihttp://hdl.handle.net/10722/148619-
dc.description.abstractTumour markers are mainly measured in clinical laboratories. A distinction should be made between tumour markers and tumour-specific markers. Utmost caution should be exercised in the interpretation of tumour-marker results because of analytical interference and overlap with benign conditions. The use of a tumour marker for early detection of malignancy is challenging because of its low positive predictive value. However, with an understanding of the performance characteristics of tumour markers and correct interpretation of the results, tumour markers are useful in clinical management of diseases.en_US
dc.languageengen_US
dc.publisherHong Kong College of Family Physicians. The Journal's web site is located at http://www.hkcfp.org.hk/en_US
dc.relation.ispartofHong Kong Practitioneren_US
dc.titleChemical pathology case conference - Serum tumour markersen_US
dc.typeArticleen_US
dc.identifier.emailLam, CW:ching-wanlam@pathology.hku.hken_US
dc.identifier.authorityLam, CW=rp00260en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.scopuseid_2-s2.0-77952040031en_US
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-77952040031&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume32en_US
dc.identifier.issue1en_US
dc.identifier.spage27en_US
dc.identifier.epage33en_US
dc.publisher.placeHong Kongen_US
dc.identifier.issnl1027-3948-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats